Found: 27
Select item for more details and to access through your institution.
Asparaginase in the treatment of non-ALL hematologic malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 875, doi. 10.1007/s00280-014-2402-3
- By:
- Publication type:
- Article
Apoptosis and KI 67 index correlate with preoperative chemotherapy efficacy and better predict the survival of gastric cancer patients with combined therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 885, doi. 10.1007/s00280-014-2410-3
- By:
- Publication type:
- Article
A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 895, doi. 10.1007/s00280-014-2418-8
- By:
- Publication type:
- Article
A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 903, doi. 10.1007/s00280-014-2420-1
- By:
- Publication type:
- Article
Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 911, doi. 10.1007/s00280-014-2421-0
- By:
- Publication type:
- Article
Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 919, doi. 10.1007/s00280-014-2422-z
- By:
- Publication type:
- Article
Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 925, doi. 10.1007/s00280-014-2423-y
- By:
- Publication type:
- Article
Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 931, doi. 10.1007/s00280-014-2424-x
- By:
- Publication type:
- Article
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 943, doi. 10.1007/s00280-014-2425-9
- By:
- Publication type:
- Article
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 951, doi. 10.1007/s00280-014-2426-8
- By:
- Publication type:
- Article
Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 961, doi. 10.1007/s00280-014-2428-6
- By:
- Publication type:
- Article
A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 975, doi. 10.1007/s00280-014-2429-5
- By:
- Publication type:
- Article
The selective Aurora-A kinase inhibitor MLN8237 (alisertib) potently inhibits proliferation of glioblastoma neurosphere tumor stem-like cells and potentiates the effects of temozolomide and ionizing radiation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 983, doi. 10.1007/s00280-014-2430-z
- By:
- Publication type:
- Article
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 991, doi. 10.1007/s00280-014-2432-x
- By:
- Publication type:
- Article
Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 999, doi. 10.1007/s00280-014-2435-7
- By:
- Publication type:
- Article
Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1009, doi. 10.1007/s00280-014-2436-6
- By:
- Publication type:
- Article
Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1021, doi. 10.1007/s00280-014-2437-5
- By:
- Publication type:
- Article
No clinically significant drug interactions between lenalidomide and P‑glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers.
- Published in:
- 2014
- By:
- Publication type:
- journal article
No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1031, doi. 10.1007/s00280-014-2438-4
- By:
- Publication type:
- Article
Pharmacokinetics, placenta, and brain uptake of paclitaxel in pregnant rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1041, doi. 10.1007/s00280-014-2439-3
- By:
- Publication type:
- Article
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1047, doi. 10.1007/s00280-014-2440-x
- By:
- Publication type:
- Article
The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1055, doi. 10.1007/s00280-014-2441-9
- By:
- Publication type:
- Article
Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1063, doi. 10.1007/s00280-014-2442-8
- By:
- Publication type:
- Article
A phase I study of oral ixabepilone in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1071, doi. 10.1007/s00280-014-2443-7
- By:
- Publication type:
- Article
Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
- Published in:
- 2014
- By:
- Publication type:
- Report
DrugPath: a database for academic investigators to match oncology molecular targets with drugs in development.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1089, doi. 10.1007/s00280-014-2433-9
- By:
- Publication type:
- Article